Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 138-146

  Wood, Robert C ^a   Wyatt, Jarrett E ^a   Bullins, Kenny W ^a   Hanley, Angela V ^a   Hanley, Gregory A ^a   Denham, James W ^b   Panus, Peter C ^a   Harirforoosh, Sam ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b East Tennessee State University   (United States)

Author keywords

Cyclooxygenase; Electrolyte; Kidney; NSAIDs; Prostaglandin; Rebamipide

Indexed keywords

CELECOXIB; DICLOFENAC; KIDNEY INJURY MOLECULE 1; NITRIC OXIDE; PLACEBO; PROSTAGLANDIN E2; REBAMIPIDE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE URINE LEVEL; HISTOPATHOLOGY; KIDNEY TUBULE NECROSIS; MALE; NEPHROTOXICITY; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; SODIUM URINE LEVEL; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

CYCLOOXYGENASE; ELECTROLYTE; KIDNEY; NSAIDS; PROSTAGLANDIN; REBAMIPIDE;

ALANINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CELL ADHESION MOLECULES; CREATININE; DICLOFENAC; DINOPROSTONE; DRUG INTERACTIONS; KIDNEY; KIDNEY DISEASES; MALE; NITRIC OXIDE; POTASSIUM; PYRAZOLES; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SULFONAMIDES;

EID: 84890128214     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.035     Document Type: Article

References (47)

1. T. Arakawa, K. Higuchi, Y. Fujiwara, T. Watanabe, K. Tominaga, E. Sasaki, N. Oshitani, T. Yoshikawa, and A.S. Tarnawski 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications Dig. Dis. Sci. 50 Suppl 1 2005 S3 S11
2. G. Aydin, N. Ozcelik, E. Cicek, and M. Soyoz Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats Hum. Exp. Toxicol. 22 2003 383 391 (Pubitemid 36987232)
3. Y. Baravalia, Y. Vaghasiya, and S. Chanda Hepatoprotective effect of Woodfordia fruticosa Kurz flowers on diclofenac sodium induced liver toxicity in rats Asian Pac. J. Trop. Med. 4 2011 342 346
4. B.S. Bloom Cost of treating arthritis and NSAID-related gastrointestinal side-effects Aliment Pharmacol. Ther. 2 Suppl 1 1988 131 138
5. K. Boku, T. Ohno, T. Saeki, H. Hayashi, I. Hayashi, M. Katori, T. Murata, S. Narumiya, K. Saigenji, and M. Majima Adaptive cytoprotection mediated by prostaglandin I(2) is attributable to sensitization of CRGP-containing sensory nerves Gastroenterology 120 2001 134 143 (Pubitemid 32061877)
6. C. Brochhausen, R. Zehbe, B. Watzer, S. Halstenberg, F. Gabler, H. Schubert, and C.J. Kirkpatrick Immobilization and controlled release of prostaglandin E2 from poly-L-lactide-co-glycolide microspheres J. Biomed. Mater. Res. A 91 2009 454 462
7. M.H. de Borst, M.M. van Timmeren, V.S. Vaidya, R.A. de Boer, M.B. van Dalen, A.B. Kramer, T.A. Schuurs, J.V. Bonventre, G. Navis, and H. van Goor Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase Am. J. Physiol. Renal Physiol. 292 2007 F313 F320
8. F.G. Delrio, Y. Park, B. Herzlich, and D. Grob Case report: diclofenac-induced rhabdomyolysis Am. J. Med. Sci. 312 1996 95 97 (Pubitemid 26275302)
9. J.E. Dinchuk, R.Q. Liu, and J.M. Trzaskos COX-3: in the wrong frame in mind Immunol. Lett. 86 2003 121 (Pubitemid 36205046)
10. W.K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J.V. Bonventre Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury Kidney Int. 62 2002 237 244 (Pubitemid 34754067)
11. C.M. Hao, and M.D. Breyer Physiological regulation of prostaglandins in the kidney Annu. Rev. Physiol. 70 2008 357 377 (Pubitemid 351738184)
12. S. Harirforoosh, A. Aghazadeh-Habashi, and F. Jamali Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent Clin. Exp. Pharmacol. Physiol. 33 2006 917 924 (Pubitemid 44427314)
13. S. Harirforoosh, and F. Jamali Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat Can. J. Physiol. Pharmacol. 83 2005 85 90 (Pubitemid 40754779)
14. S. Harirforoosh, and F. Jamali Renal adverse effects of nonsteroidal anti-inflammatory drugs Expert Opin. Drug Saf. 8 2009 669 681
15. K. Haruma, and M. Ito Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide Aliment Pharmacol. Ther. 18 Suppl 1 2003 153 159 (Pubitemid 36898013)
16. E.V. Hersh, E.T. Lally, and P.A. Moore Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Curr. Med. Res. Opin. 21 2005 1217 1226 (Pubitemid 41140725)
17. D. Hoffmann, M. Adler, V.S. Vaidya, E. Rached, L. Mulrane, W.M. Gallagher, J.J. Callanan, J.C. Gautier, K. Matheis, F. Staedtler, F. Dieterle, A. Brandenburg, A. Sposny, P. Hewitt, H. Ellinger-Ziegelbauer, J.V. Bonventre, W. Dekant, and A. Mally Performance of novel kidney biomarkers in preclinical toxicity studies Toxicol. Sci.: Off. J. Soc. Toxicol. 116 2010 8 22
18. T. Ishihara, K. Tanaka, S. Tashiro, K. Yoshida, and T. Mizushima Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis Biochem. Pharmacol. 79 2010 1622 1633
19. B. Kaplan, and R.A. Swain NSAIDs. Are there any differences? Arch. Fam. Med. 2 1993 1167 1174
20. J.E. Keeble, and P.K. Moore Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs Br. J. Pharmacol. 137 2002 295 310
21. H.K. Kim, J.I. Kim, J.K. Kim, J.Y. Han, S.H. Park, K.Y. Choi, and I.S. Chung Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers Dig. Dis. Sci. 52 2007 1776 1782
22. J.N. King, J. Dawson, R.E. Esser, R. Fujimoto, E.F. Kimble, W. Maniara, P.J. Marshall, L. O'Byrne, E. Quadros, P.L. Toutain, and P. Lees Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2 J. Vet. Pharmacol. Ther. 32 2009 1 17
23. K. Kobayashi, T. Arakawa, H. Nakamura, S. Chono, H. Yamada, H. Satoh, T. Kamata, and T. Ono Protective action of endogenous prostacyclin (PGI2) and prostaglandin E2 (PGE2) in endoscopic polypectomy-induced human ulcers Gastroenterol. Jpn. 17 1982 430 433 (Pubitemid 13138159)
24. S.J. Konturek, T. Brzozowski, I. Piastucki, T. Radecki, A. Dembinski, and A. Dembinska-Kiec Role of locally generated prostaglandins in adaptive gastric cytoprotection Dig. Dis. Sci. 27 1982 967 971 (Pubitemid 13233059)
25. L. Laine, L. Connors, M.R. Griffin, S.P. Curtis, A. Kaur, and C.P. Cannon Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines Aliment Pharmacol. Ther. 30 2009 767 774
26. J.L. Lee, H. Mukhtar, D.R. Bickers, L. Kopelovich, and M. Athar Cyclooxygenases in the skin: pharmacological and toxicological implications Toxicol. Appl. Pharmacol. 192 2003 294 306 (Pubitemid 37311345)
27. F. McKenna, D. Borenstein, H. Wendt, C. Wallemark, J.B. Lefkowith, and G.S. Geis Celecoxib versus diclofenac in the management of osteoarthritis of the knee Scand. J. Rheumatol. 30 2001 11 18
28. H. Mizoguchi, Y. Ogawa, K. Kanatsu, A. Tanaka, S. Kato, and K. Takeuchi Protective effect of rebamipide on indomethacin-induced intestinal damage in rats J. Gastroenterol. Hepatol. 16 2001 1112 1119 (Pubitemid 32990106)
29. H. Murata, Y. Yabe, S. Tsuji, M. Tsujii, H.Y. Fu, K. Asahi, H. Eguchi, S. Kawano, and N. Hayashi Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells Dig. Dis. Sci. 50 Suppl 1 2005 S70 S75
30. M.D. Murray, and D.C. Brater Renal toxicity of the nonsteroidal anti-inflammatory drugs Annu. Rev. Pharmacol. Toxicol. 33 1993 435 465 (Pubitemid 23116014)
31. Y. Niwa, M. Nakamura, N. Ohmiya, O. Maeda, T. Ando, A. Itoh, Y. Hirooka, and H. Goto Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study J. Gastroenterol. 43 2008 270 276 (Pubitemid 351650037)
32. L.G. Portney, and M.P. Watkins Foundations of Clinical Research: Applications to Practice 3rd ed. 2009 Pearson/Prentice Hall Upper Saddle River, N.J
33. A. Risser, D. Donovan, J. Heintzman, and T. Page NSAID prescribing precautions Am. Fam. Physician 80 2009 1371 1378
34. K. Sakurai, H. Sasabe, T. Koga, and T. Konishi Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product Free Radical Res. 38 2004 487 494 (Pubitemid 38618370)
35. K. Seibert, Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee, and P. Isakson Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain Proc. Natl. Acad. Sci. USA 91 1994 12013 12017 (Pubitemid 24368594)
36. B.S. Shin, C.H. Kim, Y.S. Jun, C.H. Yoon, J.I. Rho, K.C. Lee, H.S. Han, and S.D. Yoo Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats Drug Dev. Ind. Pharm. 30 2004 869 876 (Pubitemid 39362871)
37. M. Sieber, D. Hoffmann, M. Adler, V.S. Vaidya, M. Clement, J.V. Bonventre, N. Zidek, E. Rached, A. Amberg, J.J. Callanan, W. Dekant, and A. Mally Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity Toxicol. Sci.: Off. J. Soc. Toxicol. 109 2009 336 349
38. S. Sozer, G. Diniz, and F. Lermioglu Effects of celecoxib in young rats: histopathological changes in tissues and alterations of oxidative stress/antioxidant defense system Arch. Pharm. Res. 34 2011 253 259
39. I. St-Louis, M. Singh, K. Brasseur, V. Leblanc, S. Parent, and E. Asselin Expression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroids Reprod. Biol. Endocrinol.: RB&E 8 2010 103
40. W.H. Sun, S. Tsuji, M. Tsujii, E.S. Gunawan, N. Kawai, A. Kimura, Y. Kakiuchi, M. Yasumaru, H. Iijima, Y. Okuda, Y. Sasaki, M. Hori, and S. Kawano Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent J. Pharmacol. Exp. Ther. 295 2000 447 452
41. T. Suzuki, N. Yoshida, N. Nakabe, Y. Isozaki, H. Kajikawa, T. Takagi, O. Handa, S. Kokura, H. Ichikawa, Y. Naito, H. Matsui, and T. Yoshikawa Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution J. Pharmacol. Sci. 106 2008 469 477 (Pubitemid 351468600)
42. N.I. Syed, F. Zehra, A.A. Syed, S. Karim, and F.Z. Khan Comparing the effects of salts of diclofenac and alminoprofen with aspirin on serum electrolytes, creatinine and urea levels in rabbits Pak. J. Pharm. Sci. 25 2012 777 782
43. T. Tanigawa, R. Pai, T. Arakawa, and A.S. Tarnawski Rebamipide inhibits gastric cancer cell growth Dig. Dis. Sci. 52 2007 240 247 (Pubitemid 46122074)
44. T. Tanigawa, T. Watanabe, F. Ohkawa, Y. Nadatani, K. Otani, H. Machida, H. Okazaki, H. Yamagami, K. Watanabe, K. Tominaga, Y. Fujiwara, K. Takeuchi, and T. Arakawa Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase J. Clin. Biochem. Nutr. 48 2011 149 153
45. L.E. Targownik, and P.A. Thomson Gastroprotective strategies among NSAID users: guidelines for appropriate use in chronic illness Can. Fam. Physician 52 2006 1100 1105 (Pubitemid 44553332)
46. V.S. Vaidya, V. Ramirez, T. Ichimura, N.A. Bobadilla, and J.V. Bonventre Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury Am. J. Physiol. Renal Physiol. 290 2006 F517 F529
47. T. Yasmeen, F. Yasmin, and G.S. Qureshi To evaluate the role of diclofenac sodium on renal parenchyma of young albino rats Pak. J. Pharm. Sci. 21 2008 98 102